Format

Send to

Choose Destination
See comment in PubMed Commons below
J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1334-6.

Smell testing: an additional tool for identification of adult Refsum's disease.

Author information

  • 1Refsum's Disease Clinic, Chelsea & Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK.

Abstract

BACKGROUND:

Adult Refsum's disease (ARD) is characterised by the presence of retinitis pigmentosa, ataxia, deafness, sensory neuropathy, and bony changes. The diagnosis is confirmed by the presence of phytanic acidaemia. Although reduced smell function has been described in ARD, its value in the diagnosis of the condition has not been fully evaluated.

OBJECTIVE:

To investigate the prevalence and degree of olfactory dysfunction in patients with ARD.

METHOD:

The olfactory function of 16 patients with ARD was assessed using the quantitative University of Pennsylvania Smell Identification Test (UPSIT).

RESULTS:

All patients had complete anosmia or grossly impaired smell function with a mean UPSIT score of 14.7 (SD 4.7) (normal > 34) despite having been treated with an appropriate diet for a median of 15 years (range 1-25).

CONCLUSIONS:

Identification of ARD patients can be facilitated by using the UPSIT in combination with the presence of retinitis pigmentosa, even if they have no neurological or bony features. Phytanic acid screening should be performed in any patient manifesting these two signs.

PMID:
15314127
PMCID:
PMC1739246
DOI:
10.1136/jnnp.2003.026690
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center